Intuitive Surgical Outperforms Lombard Medical in Financial Comparison

Analysis shows Intuitive Surgical has stronger consensus rating and upside potential than Lombard Medical.

Mar. 14, 2026 at 10:50am

A financial comparison between medical device companies Lombard Medical (OTCMKTS:EVARF) and Intuitive Surgical (NASDAQ:ISRG) reveals that Intuitive Surgical outperforms Lombard Medical across key metrics like valuation, profitability, institutional ownership, and analyst recommendations.

Why it matters

This analysis provides investors with a detailed look at the relative strengths and weaknesses of these two medical technology firms, helping them make more informed decisions about where to allocate their capital.

The details

The comparison shows that Intuitive Surgical has a stronger consensus rating from analysts, with a target price indicating 30.44% upside potential. Intuitive Surgical also has much higher institutional ownership at 83.6% versus just 0.7% for Lombard Medical. In terms of profitability, Intuitive Surgical outperforms Lombard Medical on measures like net margins, return on equity, and return on assets.

  • The financial analysis was published on March 14, 2026.

The players

Lombard Medical

A medical technology company that develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms.

Intuitive Surgical

A company that develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights Intuitive Surgical's superior financial performance and market positioning compared to Lombard Medical, making it an attractive investment option for those looking to capitalize on growth in the medical technology sector.